New Products
New Products
Express Art FFPE mRNA amplification kit
for formalin-fixed paraffin-embedded samples
»
more information »
kit manual
» product catalogue
ExpressArt FFPE
mRNA Amplification kit Key Features
- Uniform and complete amplification of mRNA fragments
with and without poly(A)(low 3‘-5‘-ratios in the range
of 1 to 3)
- High presence calls for clinical FFPE samples
- microarray platforms with a single probe per gene:
up to 100% of parallel cryo samples e.g. with Novartis
NovaChips
- microarray platfors with multiple probes per gene:
up to 50% of parallel cryo samples e.g. Affymetrix
GeneChips (probe sets) "X3P GeneChips" the special
adaptation to FFPE samples is not required.
- High concordance for differentially expressed genes
- qualitative in Decrease or Increase
- quantitative in Fold Changes
»
FFPE-Presentation (PDF-file, 131 KB)
|
NucleoGuard (NG)
a universal RNase / nuclease inhibitor for improved RNA stabilisation
and for disruption of nucleic acid aggregates in FFPE samples
»
more information »
user manual »
product catalogue
NucleoGuard (NG)
is a small molecular weight, isotrophic reagent that acts
as a mimic for nucleic acids and is useful in the isolation
of RNA from very small samples (<10 ng RNA) and/or difficult
samples, with special benefits for FFPE samples.
- Its high concentration leads to effective inhibition
of all nucleic acid recognition reactions, including
the activities of RNases, nucleases, etc., and of polymerases.
- Its effective removal with standard spin columns results
in no interference with down-stream applications, e.g.
reverse transcription
- For FFPE samples, its high concentration leads to
(partial) disruption of nucleic acid aggregates and
improved RNA recovery (see also DeCrossLinker)
|
DeCrossLinker (DCL)
for partial reversion of cross-links in FFPE samples
»
more information »
user manual »
product catalogue
DeCrossLinker (DCL)
is a small molecular weight reagent for the (partial) reversion
of cross-links in FFPE samples, like RNA-protein, RNA-RNA
and RNA-DNA cross-links.
Its use leads to
- increased liberation of RNAs
- reduced stop sites for reverse transcriptase
- (partial) disruption of nucleic acid aggregates, which
is especially effective in combination with NucleoGuard
This results in more efficient template RNAs for reverse
transcriptase, as evident in reduced PCR cycle numbers (4
to 7) in quantitative RT-PCRs.
|
|